Dennis Langer's Net Worth
Estimate Recalculated Jun 14, 2025 12:10AM EST
Who is Dennis Langer
Dennis Langer has an estimated net worth of $7.78 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, PHARMACOPEIA DRUG DISCOVERY INC, Myriad Pharmaceuticals, Inc., MYRIAD GENETICS INC, DELCATH SYSTEMS, INC., Brooklyn ImmunoTherapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, Quoin Pharmaceuticals, Ltd., PERNIX THERAPEUTICS HOLDINGS, INC., TRANSKARYOTIC THERAPIES INC, SIRNA THERAPEUTICS INC, and CYTOGEN CORP.
SEC CIK
Dennis Langer's CIK is 0001274225
Past Insider Trading and Trends
2007 was Dennis Langer's most active year for acquiring shares with 19 total transactions. Dennis Langer's most active month to acquire stocks was the month of November. 2007 was Dennis Langer's most active year for disposing of shares, totalling 30 transactions. Dennis Langer's most active month to dispose stocks was the month of November. 2021 saw Dennis Langer paying a total of $761,700.00 for 109,848 shares, this is the most they've acquired in one year. In 2018 Dennis Langer cashed out on 194,531 shares for a total of $4,081,612.03, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
